Covishield side effects: AstraZeneca expresses 'sympathy' for those who lost loved ones

Following AstraZeneca's acknowledgment of a rare side effect associated with its COVID-19 vaccine, known as Covishield in India, the UK pharmaceutical giant extended sympathy to those impacted. Reaffirming its dedication to patient safety amidst concerns about potential rare side effects, AstraZeneca emphasised the vaccine's overall safety profile. The company underscored the stringent standards of regulatory authorities to ensure the safe use of medicines, including vaccines. AstraZeneca highlighted the extensive clinical trial data and real-world evidence consistently supporting the safety and efficacy of the vaccine.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/F0dLfzQ
via IFTTT

Read More

Lilavati trustee alleges Rs 500 crore scam by kin

Prashant Mehta, a trustee of Lilavati Hospital & Research Centre in Mumbai, accused former trustees of misappropriating ₹500 crore in trust funds. Allegations include payments for private disputes, bogus donations, and advances to real estate firms. Prashant named his late uncle Vijay Mehta, cousin Niket Mehta, and aunt Sushila Mehta in the accusations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/js6y31F
via IFTTT

Read More

Covishield row: 'Very rare chances…', ex-AIIMS doctor explains severe side-effects of covid vaccine

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/SIqJXtn
via IFTTT

Read More

Covishield Case: Bereaved parents to take Serum Institute of India to Court following AstraZeneca's rare side effect admission

The parents of a woman allegedly deceased after receiving the Covishield vaccine plan to file a case against the Serum Institute of India (SII). This decision follows AstraZeneca's acknowledgment in court that their Covid shot can cause a rare side effect, providing hope for the parents in seeking justice. AstraZeneca faces a class-action lawsuit over allegations that its vaccine, developed with the University of Oxford, led to deaths and serious injuries, including thrombosis with thrombocytopenia syndrome (TTS), characterized by blood clots and low platelet count.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/B1uRIk9
via IFTTT

Read More

Covishield Side Effects: What's TTS syndrome, symptoms, and danger signs you shouldn't ignore

Covishield TTS: AstraZeneca has acknowledged the potential TTS side effects from its COVID-19 vaccine Covishield, used widely in India. TTS, Thrombosis with Thrombocytopenia Syndrome, is rare but serious, marked by blood clots and low platelet levels. Symptoms include headaches, blurred vision, and chest pain. Dr. Jayadevan emphasizes awareness, stressing early treatment for effective management. AstraZeneca's admission follows reports of TTS linked to adenovirus vector vaccines.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0iDEpzW
via IFTTT

Read More

Indian pharmaceutical industry set for major transformation: Dilip Shanghvi

At an annual meeting of the USA-India Chamber of Commerce in Boston, Shanghvi told a gathering of leading multinational drug makers about the "clear positive improvements" that are taking place in India. Sun Pharma itself has built a pipeline of over 10 specialty and innovative drugs in the US. It's done this through acquisitions of late-stage drugs in clinical trials and building commercial teams around them. For Indian companies that have grown by making copies of innovative drugs, gaining presence in innovative drugs is considered tough as this segment is dominated by giant corporations such as Pfizer, Novartis, Roche, Eli Lilly and Bristol Myers Squibb.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cUHOp9a
via IFTTT

Read More

Drug firms told to set up system for 'prompt' recalls

India enforced 'Schedule M' for drug manufacturers, emphasizing quality, recall systems. Companies must comply with strict rules on hygiene, audits, and reporting defects to DCGI for improved drug quality and safety measures. For seamless implementation of the new rules, the health ministry has been conducting workshops and giving presentations to pharma companies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/F0SB3ri
via IFTTT

Read More